TY - JOUR AU - Dalal, A. A. AU - Duh, M. S. AU - Gozalo, L. AU - Robitaille, M. N. AU - Albers, F. AU - Yancey, S. PY - 2016 DA - 2016// TI - Dose-response relationship between long-term systemic corticosteroid use and related complications in patients with severe asthma JO - J Manag Care Spec Pharm. VL - 22 ID - Dalal2016 ER - TY - JOUR AU - Sarnes, E. AU - Crofford, L. AU - Watson, M. AU - Dennis, G. AU - Kan, H. AU - Bass, D. PY - 2011 DA - 2011// TI - Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review JO - Clin Ther VL - 33 UR - https://doi.org/10.1016/j.clinthera.2011.09.009 DO - 10.1016/j.clinthera.2011.09.009 ID - Sarnes2011 ER - TY - JOUR AU - Sullivan, P. W. AU - Ghushchyan, V. H. AU - Globe, G. AU - Schatz, M. PY - 2018 DA - 2018// TI - Oral corticosteroid exposure and adverse effects in asthmatic patients JO - J Allergy Clin Immunol. VL - 141 UR - https://doi.org/10.1016/j.jaci.2017.04.009 DO - 10.1016/j.jaci.2017.04.009 ID - Sullivan2018 ER - TY - STD TI - Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and prevention. Available from: http://www.ginasthma.org/. 2019. UR - http://www.ginasthma.org/ ID - ref4 ER - TY - JOUR AU - Normansell, R. AU - Walker, S. AU - Milan, S. J. AU - Walters, E. H. AU - Nair, P. PY - 2014 DA - 2014// TI - Omalizumab for asthma in adults and children JO - Cochrane Database Syst Rev. VL - 1 ID - Normansell2014 ER - TY - JOUR AU - Rodrigo, G. J. AU - Neffen, H. PY - 2015 DA - 2015// TI - Systematic review on the use of omalizumab for the treatment of asthmatic children and adolescents JO - Pediatr Allergy Immunol VL - 26 UR - https://doi.org/10.1111/pai.12405 DO - 10.1111/pai.12405 ID - Rodrigo2015 ER - TY - JOUR AU - Haldar, P. AU - Brightling, C. E. AU - Hargadon, B. AU - Gupta, S. AU - Monteiro, W. AU - Sousa, A. PY - 2009 DA - 2009// TI - Mepolizumab and exacerbations of refractory eosinophilic asthma JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0808991 DO - 10.1056/NEJMoa0808991 ID - Haldar2009 ER - TY - JOUR AU - Pavord, I. D. AU - Korn, S. AU - Howarth, P. AU - Bleecker, E. R. AU - Buhl, R. AU - Keene, O. N. PY - 2012 DA - 2012// TI - Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial JO - Lancet VL - 380 UR - https://doi.org/10.1016/S0140-6736(12)60988-X DO - 10.1016/S0140-6736(12)60988-X ID - Pavord2012 ER - TY - JOUR AU - Nair, P. AU - Wenzel, S. AU - Rabe, K. F. AU - Bourdin, A. AU - Lugogo, N. L. AU - Kuna, P. PY - 2017 DA - 2017// TI - Oral glucocorticoid-sparing effect of benralizumab in severe asthma JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1703501 DO - 10.1056/NEJMoa1703501 ID - Nair2017 ER - TY - JOUR AU - Castro, M. AU - Corren, J. AU - Pavord, I. D. AU - Maspero, J. AU - Wenzel, S. AU - Rabe, K. F. PY - 2018 DA - 2018// TI - Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1804092 DO - 10.1056/NEJMoa1804092 ID - Castro2018 ER - TY - JOUR AU - Baker, D. L. AU - Nakamura, G. R. AU - Lowman, H. B. AU - Fischer, S. K. PY - 2016 DA - 2016// TI - Evaluation of ige antibodies to omalizumab (Xolair(r)) and their potential correlation to anaphylaxis JO - AAPS J VL - 18 UR - https://doi.org/10.1208/s12248-015-9821-x DO - 10.1208/s12248-015-9821-x ID - Baker2016 ER - TY - JOUR AU - Kim, H. L. AU - Leigh, R. AU - Becker, A. PY - 2010 DA - 2010// TI - Omalizumab: practical considerations regarding the risk of anaphylaxis JO - Allergy Asthma Clin Immunol. VL - 6 UR - https://doi.org/10.1186/1710-1492-6-32 DO - 10.1186/1710-1492-6-32 ID - Kim2010 ER - TY - JOUR AU - Lieberman, P. L. AU - Jones, I. AU - Rajwanshi, R. AU - Rosen, K. AU - Umetsu, D. T. PY - 2017 DA - 2017// TI - Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics JO - J Allergy Clin Immunol. VL - 140 UR - https://doi.org/10.1016/j.jaci.2017.07.013 DO - 10.1016/j.jaci.2017.07.013 ID - Lieberman2017 ER - TY - JOUR AU - Lieberman, P. L. AU - Umetsu, D. T. AU - Carrigan, G. J. AU - Rahmaoui, A. PY - 2016 DA - 2016// TI - Anaphylactic reactions associated with omalizumab administration: Analysis of a case-control study JO - J Allergy Clin Immunol. VL - 138 UR - https://doi.org/10.1016/j.jaci.2016.03.030 DO - 10.1016/j.jaci.2016.03.030 ID - Lieberman2016 ER - TY - JOUR AU - Limb, S. L. AU - Starke, P. R. AU - Lee, C. E. AU - Chowdhury, B. A. PY - 2007 DA - 2007// TI - Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma JO - J Allergy Clin Immunol. VL - 120 UR - https://doi.org/10.1016/j.jaci.2007.09.022 DO - 10.1016/j.jaci.2007.09.022 ID - Limb2007 ER - TY - JOUR AU - Pichler, W. J. PY - 2006 DA - 2006// TI - Adverse side-effects to biological agents JO - Allergy VL - 61 UR - https://doi.org/10.1111/j.1398-9995.2006.01058.x DO - 10.1111/j.1398-9995.2006.01058.x ID - Pichler2006 ER - TY - JOUR AU - Price, K. S. AU - Hamilton, R. G. PY - 2007 DA - 2007// TI - Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy JO - Allergy Asthma Proc. VL - 28 UR - https://doi.org/10.2500/aap.2007.28.3003 DO - 10.2500/aap.2007.28.3003 ID - Price2007 ER - TY - JOUR AU - Khatri, S. AU - Moore, W. AU - Gibson, P. G. AU - Leigh, R. AU - Bourdin, A. AU - Maspero, J. PY - 2019 DA - 2019// TI - Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma JO - J Allergy Clin Immunol. VL - 143 UR - https://doi.org/10.1016/j.jaci.2018.09.033 DO - 10.1016/j.jaci.2018.09.033 ID - Khatri2019 ER - TY - JOUR AU - Lugogo, N. AU - Domingo, C. AU - Chanez, P. AU - Leigh, R. AU - Gilson, M. J. AU - Price, R. G. PY - 2016 DA - 2016// TI - long-term efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a multi-center, open-label, phase IIIb study JO - Clin Ther. VL - 38 UR - https://doi.org/10.1016/j.clinthera.2016.07.010 DO - 10.1016/j.clinthera.2016.07.010 ID - Lugogo2016 ER - TY - STD TI - Benralizumab (Fasenra) for Severe Eosinophilic Asthma. JAMA. 2018;319(14):1501-2. ID - ref20 ER - TY - STD TI - Asthma prevention and management guidelines 2015, Japan. 2015. ID - ref21 ER - TY - JOUR AU - Chung, K. F. AU - Wenzel, S. E. AU - Brozek, J. L. AU - Bush, A. AU - Castro, M. AU - Sterk, P. J. PY - 2014 DA - 2014// TI - International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma JO - Eur Respir J VL - 43 UR - https://doi.org/10.1183/09031936.00202013 DO - 10.1183/09031936.00202013 ID - Chung2014 ER - TY - JOUR AU - Bautista, E. AU - Simons, F. E. AU - Simons, K. J. AU - Becker, A. B. AU - Duke, K. AU - Tillett, M. PY - 2002 DA - 2002// TI - Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock JO - Int Arch Allergy Immunol VL - 128 UR - https://doi.org/10.1159/000059406 DO - 10.1159/000059406 ID - Bautista2002 ER - TY - JOUR AU - Soar, J. AU - Pumphrey, R. AU - Cant, A. AU - Clarke, S. AU - Corbett, A. AU - Dawson, P. PY - 2008 DA - 2008// TI - Emergency treatment of anaphylactic reactions–guidelines for healthcare providers JO - Resuscitation. VL - 77 UR - https://doi.org/10.1016/j.resuscitation.2008.02.001 DO - 10.1016/j.resuscitation.2008.02.001 ID - Soar2008 ER - TY - JOUR AU - Fineman, S. M. PY - 2014 DA - 2014// TI - Optimal treatment of anaphylaxis: antihistamines versus epinephrine JO - Postgrad Med VL - 126 UR - https://doi.org/10.3810/pgm.2014.07.2785 DO - 10.3810/pgm.2014.07.2785 ID - Fineman2014 ER - TY - JOUR AU - Simons, F. E. AU - Ardusso, L. R. AU - Bilo, M. B. AU - El-Gamal, Y. M. AU - Ledford, D. K. AU - Ring, J. PY - 2011 DA - 2011// TI - World allergy organization guidelines for the assessment and management of anaphylaxis JO - World Allergy Organ J. VL - 4 UR - https://doi.org/10.1097/WOX.0b013e318211496c DO - 10.1097/WOX.0b013e318211496c ID - Simons2011 ER - TY - JOUR AU - Bock, S. A. AU - Munoz-Furlong, A. AU - Sampson, H. A. PY - 2007 DA - 2007// TI - Further fatalities caused by anaphylactic reactions to food, 2001-2006 JO - J Allergy Clin Immunol. VL - 119 UR - https://doi.org/10.1016/j.jaci.2006.12.622 DO - 10.1016/j.jaci.2006.12.622 ID - Bock2007 ER - TY - JOUR AU - Gallagher, M. AU - Worth, A. AU - Cunningham-Burley, S. AU - Sheikh, A. PY - 2011 DA - 2011// TI - Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland JO - UK Clin Exp Allergy. VL - 41 UR - https://doi.org/10.1111/j.1365-2222.2011.03743.x DO - 10.1111/j.1365-2222.2011.03743.x ID - Gallagher2011 ER - TY - JOUR AU - Grabenhenrich, L. B. AU - Dolle, S. AU - Rueff, F. AU - Renaudin, J. M. AU - Scherer, K. AU - Pfohler, C. PY - 2018 DA - 2018// TI - Epinephrine in severe allergic reactions: the european anaphylaxis register JO - J Allergy Clin Immunol Pract. VL - 6 UR - https://doi.org/10.1016/j.jaip.2018.02.026 DO - 10.1016/j.jaip.2018.02.026 ID - Grabenhenrich2018 ER - TY - JOUR AU - Campbell, D. E. PY - 2019 DA - 2019// TI - Anaphylaxis management: time to re-evaluate the role of corticosteroids JO - J Allergy Clin Immunol Pract. VL - 7 UR - https://doi.org/10.1016/j.jaip.2019.07.005 DO - 10.1016/j.jaip.2019.07.005 ID - Campbell2019 ER - TY - JOUR AU - Turner, P. J. AU - Campbell, D. E. AU - Motosue, M. S. AU - Campbell, R. L. PY - 2019 DA - 2019// TI - Global trends in anaphylaxis epidemiology and clinical implications JO - J Allergy Clin Immunol Pract. VL - 8 UR - https://doi.org/10.1016/j.jaip.2019.11.027 DO - 10.1016/j.jaip.2019.11.027 ID - Turner2019 ER - TY - JOUR AU - Turner, P. J. AU - Jerschow, E. AU - Umasunthar, T. AU - Lin, R. AU - Campbell, D. E. AU - Boyle, R. J. PY - 2017 DA - 2017// TI - Fatal anaphylaxis: mortality rate and risk factors JO - J Allergy Clin Immunol Pract. VL - 5 UR - https://doi.org/10.1016/j.jaip.2017.06.031 DO - 10.1016/j.jaip.2017.06.031 ID - Turner2017 ER - TY - JOUR AU - Galli, S. J. AU - Tsai, M. AU - Piliponsky, A. M. PY - 2008 DA - 2008// TI - The development of allergic inflammation JO - Nature VL - 454 UR - https://doi.org/10.1038/nature07204 DO - 10.1038/nature07204 ID - Galli2008 ER - TY - JOUR AU - Hashimoto, S. AU - Bel, E. H. PY - 2012 DA - 2012// TI - Current treatment of severe asthma JO - Clin Exp Allergy VL - 42 UR - https://doi.org/10.1111/j.1365-2222.2011.03936.x DO - 10.1111/j.1365-2222.2011.03936.x ID - Hashimoto2012 ER - TY - JOUR AU - Wechsler, M. E. AU - Laviolette, M. AU - Rubin, A. S. AU - Fiterman, J. AU - Lapa e Silva, J. R. AU - Shah, P. L. PY - 2013 DA - 2013// TI - Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma JO - J Allergy Clin Immunol. VL - 132 UR - https://doi.org/10.1016/j.jaci.2013.08.009 DO - 10.1016/j.jaci.2013.08.009 ID - Wechsler2013 ER - TY - JOUR AU - Cox, L. AU - Platts-Mills, T. A. AU - Finegold, I. AU - Schwartz, L. B. AU - Simons, F. E. AU - Wallace, D. V. PY - 2007 DA - 2007// TI - american academy of allergy, asthma & immunology/American college of allergy, asthma and immunology joint task force report on omalizumab-associated anaphylaxis JO - J Allergy Clin Immunol. VL - 120 UR - https://doi.org/10.1016/j.jaci.2007.09.032 DO - 10.1016/j.jaci.2007.09.032 ID - Cox2007 ER - TY - JOUR AU - Hoffmann, C. AU - Blume, A. AU - Miller, I. AU - Garidel, P. PY - 2009 DA - 2009// TI - Insights into protein-polysorbate interactions analysed by means of isothermal titration and differential scanning calorimetry JO - Eur Biophys J VL - 38 UR - https://doi.org/10.1007/s00249-009-0404-6 DO - 10.1007/s00249-009-0404-6 ID - Hoffmann2009 ER - TY - JOUR AU - Steele, R. H. AU - Limaye, S. AU - Cleland, B. AU - Chow, J. AU - Suranyi, M. G. PY - 2005 DA - 2005// TI - Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin JO - Nephrology VL - 10 UR - https://doi.org/10.1111/j.1440-1797.2005.00389.x DO - 10.1111/j.1440-1797.2005.00389.x ID - Steele2005 ER - TY - JOUR AU - Heinzerling, L. AU - Mari, A. AU - Bergmann, K. C. AU - Bresciani, M. AU - Burbach, G. AU - Darsow, U. PY - 2013 DA - 2013// TI - The skin prick test—European standards JO - Clin Transl Allergy. VL - 3 UR - https://doi.org/10.1186/2045-7022-3-3 DO - 10.1186/2045-7022-3-3 ID - Heinzerling2013 ER - TY - JOUR AU - Nyfeler, B. AU - Pichler, W. J. PY - 1997 DA - 1997// TI - The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity JO - Clin Exp Allergy VL - 27 UR - https://doi.org/10.1111/j.1365-2222.1997.tb00690.x DO - 10.1111/j.1365-2222.1997.tb00690.x ID - Nyfeler1997 ER - TY - JOUR AU - Saito, D. AU - Hayashida, M. AU - Sato, T. AU - Minowa, S. AU - Ikezaki, O. AU - Mitsui, T. PY - 2018 DA - 2018// TI - Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy JO - Intest Res. VL - 16 UR - https://doi.org/10.5217/ir.2018.16.2.273 DO - 10.5217/ir.2018.16.2.273 ID - Saito2018 ER - TY - JOUR AU - Tokuwaka, J. AU - Takahashi, S. AU - Tanaka, M. PY - 2013 DA - 2013// TI - Anaphylaxis after sugammadex administration JO - Can J Anaesth VL - 60 UR - https://doi.org/10.1007/s12630-013-9931-9 DO - 10.1007/s12630-013-9931-9 ID - Tokuwaka2013 ER - TY - JOUR AU - Fujisaki, A. AU - Kondo, Y. AU - Goto, K. AU - Morita, T. PY - 2012 DA - 2012// TI - Life-threatening anaphylaxis to leuprorelin acetate depot: case report and review of the literature JO - Int J Urol VL - 19 UR - https://doi.org/10.1111/j.1442-2042.2011.02886.x DO - 10.1111/j.1442-2042.2011.02886.x ID - Fujisaki2012 ER - TY - JOUR AU - Mochitomi, Y. AU - Inoue, A. AU - Kawabata, H. AU - Ishida, S. AU - Kanzaki, T. PY - 1998 DA - 1998// TI - Stevens-Johnson syndrome caused by a health drink (Eberu) containing ophiopogonis tuber JO - J Dermatol VL - 25 UR - https://doi.org/10.1111/j.1346-8138.1998.tb02477.x DO - 10.1111/j.1346-8138.1998.tb02477.x ID - Mochitomi1998 ER - TY - JOUR AU - Arima, M. AU - Kanoh, T. AU - Yamasaki, A. AU - Matsuda, S. AU - Kasuya, H. AU - Sunayama, S. PY - 1998 DA - 1998// TI - Eosinophilic myocarditis associated with toxicodermia caused by phenobarbital JO - Jpn Circ J VL - 62 UR - https://doi.org/10.1253/jcj.62.132 DO - 10.1253/jcj.62.132 ID - Arima1998 ER - TY - JOUR AU - Yoshimura, T. AU - Kurita, C. AU - Hayata, M. AU - Nagai, H. PY - 1993 DA - 1993// TI - Diagnosis of drug allergy by the lymphocyte stimulation test with the MTT [3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay JO - Biol Pharm Bull VL - 16 UR - https://doi.org/10.1248/bpb.16.686 DO - 10.1248/bpb.16.686 ID - Yoshimura1993 ER - TY - JOUR AU - Akin, C. AU - Valent, P. AU - Metcalfe, D. D. PY - 2010 DA - 2010// TI - Mast cell activation syndrome: proposed diagnostic criteria JO - J Allergy Clin Immunol. VL - 126 UR - https://doi.org/10.1016/j.jaci.2010.08.035 DO - 10.1016/j.jaci.2010.08.035 ID - Akin2010 ER - TY - JOUR AU - Schwartz, L. B. PY - 2006 DA - 2006// TI - Diagnostic value of tryptase in anaphylaxis and mastocytosis JO - Immunol Allergy Clin North Am. VL - 26 UR - https://doi.org/10.1016/j.iac.2006.05.010 DO - 10.1016/j.iac.2006.05.010 ID - Schwartz2006 ER - TY - JOUR AU - Brockow, K. AU - Jofer, C. AU - Behrendt, H. AU - Ring, J. PY - 2008 DA - 2008// TI - Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients JO - Allergy VL - 63 UR - https://doi.org/10.1111/j.1398-9995.2007.01569.x DO - 10.1111/j.1398-9995.2007.01569.x ID - Brockow2008 ER - TY - JOUR AU - Bonadonna, P. AU - Perbellini, O. AU - Passalacqua, G. AU - Caruso, B. AU - Colarossi, S. AU - Fior, D. PY - 2009 DA - 2009// TI - Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels JO - J Allergy Clin Immunol. VL - 123 UR - https://doi.org/10.1016/j.jaci.2008.11.018 DO - 10.1016/j.jaci.2008.11.018 ID - Bonadonna2009 ER - TY - JOUR AU - Valent, P. AU - Akin, C. AU - Bonadonna, P. AU - Hartmann, K. AU - Brockow, K. AU - Niedoszytko, M. PY - 2019 DA - 2019// TI - Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome JO - J Allergy Clin Immunol Pract. VL - 7 UR - https://doi.org/10.1016/j.jaip.2019.01.006 DO - 10.1016/j.jaip.2019.01.006 ID - Valent2019 ER -